NASDAQ:HSKA - Heska Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$101.79 -0.32 (-0.31 %)
(As of 05/25/2018 04:00 PM ET)
Previous Close$101.79
Today's Range$101.26 - $102.92
52-Week Range$56.59 - $115.00
Volume38,061 shs
Average Volume98,507 shs
Market Capitalization$761.62 million
P/E Ratio49.17
Dividend YieldN/A

About Heska (NASDAQ:HSKA)

Heska logoHeska Corporation manufactures, sells, and markets veterinary diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Europe, and internationally. The company's Core Companion Animal Health segment offers Element DC and DRI-CHEM 7000 veterinary chemistry analyzers for blood chemistry and electrolyte analysis; HT5 and HEMATRUE veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; COAG veterinary analyzers; Element i immunodiagnostic analyzers; and IV infusion pumps. This segment also provides veterinary imaging instruments and services, such as digital radiography solutions and ultrasound systems, as well as sells mobile digital radiography products; Cloudbank, a Web-based image storage solution; ViewCloud, a picture archival and communications system for Cloudbank; point-of-care heartworm diagnostic test products for dogs and cats; TRI-HEART Plus chewable tablets for the treatment of canine heartworm infection, and treatment and control of ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels, and therapy shots or drops. Its Other Vaccines, Pharmaceuticals and Products segment offers bovine vaccines primarily under the Titanium and MasterGuard brands; biological and pharmaceutical products for other animal health companies; and various turnkey services comprising research, licensing, production, labeling, and packaging, as well as provides validation support and distribution services. The company sells its products to veterinarians through a field organization, a telephone sales force, and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. Heska Corporation was founded in 1988 and is headquartered in Loveland, Colorado.

Receive HSKA News and Ratings via Email

Sign-up to receive the latest news and ratings for HSKA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biological products, except diagnostic


Debt-to-Equity RatioN/A
Current Ratio2.68
Quick Ratio1.39


Trailing P/E Ratio49.17
Forward P/E Ratio60.59
P/E GrowthN/A

Sales & Book Value

Annual Sales$129.34 million
Price / Sales5.87
Cash Flow$2.8354 per share
Price / Cash35.90
Book Value$14.09 per share
Price / Book7.22


EPS (Most Recent Fiscal Year)$2.07
Net Income$9.95 million
Net Margins5.57%
Return on Equity13.30%
Return on Assets10.01%


Outstanding Shares7,460,000

Heska (NASDAQ:HSKA) Frequently Asked Questions

What is Heska's stock symbol?

Heska trades on the NASDAQ under the ticker symbol "HSKA."

How were Heska's earnings last quarter?

Heska Co. (NASDAQ:HSKA) issued its earnings results on Friday, May, 4th. The medical research company reported $0.28 EPS for the quarter, missing the Zacks' consensus estimate of $0.40 by $0.12. The medical research company earned $32.77 million during the quarter, compared to analysts' expectations of $31.65 million. Heska had a net margin of 5.57% and a return on equity of 13.30%. View Heska's Earnings History.

When is Heska's next earnings date?

Heska is scheduled to release their next quarterly earnings announcement on Monday, July, 30th 2018. View Earnings Estimates for Heska.

What price target have analysts set for HSKA?

6 analysts have issued 1 year price targets for Heska's stock. Their forecasts range from $93.00 to $143.00. On average, they expect Heska's stock price to reach $114.90 in the next twelve months. View Analyst Ratings for Heska.

What are Wall Street analysts saying about Heska stock?

Here are some recent quotes from research analysts about Heska stock:
  • 1. According to Zacks Investment Research, "Heska Corporation sells advanced veterinary diagnostic and specialty products. Heska's state-of-the-art offerings include blood testing instruments and supplies, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The Company's core focus is on the canine and feline markets where it strives to provide high value products and unparalleled support to veterinarians. " (5/23/2018)
  • 2. B. Riley analysts commented, "We expect Q3 results to be generally in line. We forecast revenue of $35.8 million and EPS of $0.40 versus consensus of $36.0 million and EPS of $0.41. We model revenue growth at 7.1%, reflecting ongoing momentum in core blood diagnostics within its Core Companion Animal Health offset by Other Vaccines, Pharmaceuticals and Products segment which pulled forward revenue last quarter (but expecting to finish off Q4 strong)." (10/27/2017)

Who are some of Heska's key competitors?

Who are Heska's key executives?

Heska's management team includes the folowing people:
  • Mr. Kevin S. Wilson, CEO, Pres & Director (Age 46)
  • Mr. Jason A. Napolitano, COO, Chief Strategist & Sec. (Age 50)
  • Ms. Catherine Grassman CPA, VP, Chief Accounting Officer & Corp. Controller (Age 42)
  • Mr. Steven M. Eyl, Exec. VP of Global Sales & Marketing (Age 52)
  • Dr. Nancy Wisnewski, Exec. VP of Diagnostic Operations & Product Devel. (Age 55)

Has Heska been receiving favorable news coverage?

Headlines about HSKA stock have been trending somewhat positive on Saturday, Accern Sentiment reports. Accern ranks the sentiment of press coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Heska earned a media sentiment score of 0.13 on Accern's scale. They also assigned media stories about the medical research company an impact score of 46.97 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next few days.

Who are Heska's major shareholders?

Heska's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (12.50%), Neuberger Berman Group LLC (8.67%), Park West Asset Management LLC (3.65%), Redmile Group LLC (3.20%), Dimensional Fund Advisors LP (2.57%) and Northern Trust Corp (1.65%). Company insiders that own Heska stock include Carol Wrenn, G Irwin Gordon, Jason A Napolitano, John Mcmahon, Kevin S Wilson, Michael J Mcginley, Nancy Wisnewski, Rod Lippincott, Sharon J Larson and Steve Asakowicz. View Institutional Ownership Trends for Heska.

Which institutional investors are selling Heska stock?

HSKA stock was sold by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, Park West Asset Management LLC, Russell Investments Group Ltd., Allianz Asset Management GmbH, Allianz Asset Management GmbH, Neuberger Berman Group LLC, Citigroup Inc. and JPMorgan Chase & Co.. Company insiders that have sold Heska company stock in the last year include John Mcmahon, Michael J Mcginley, Nancy Wisnewski, Rod Lippincott and Steve Asakowicz. View Insider Buying and Selling for Heska.

Which institutional investors are buying Heska stock?

HSKA stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., American Century Companies Inc., Tygh Capital Management Inc., Redmile Group LLC, Millennium Management LLC, Citadel Advisors LLC, WINTON GROUP Ltd and GSA Capital Partners LLP. View Insider Buying and Selling for Heska.

How do I buy shares of Heska?

Shares of HSKA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Heska's stock price today?

One share of HSKA stock can currently be purchased for approximately $101.79.

How big of a company is Heska?

Heska has a market capitalization of $761.62 million and generates $129.34 million in revenue each year. The medical research company earns $9.95 million in net income (profit) each year or $2.07 on an earnings per share basis. Heska employs 345 workers across the globe.

How can I contact Heska?

Heska's mailing address is 3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO, 80538. The medical research company can be reached via phone at 970-493-7272 or via email at [email protected]

MarketBeat Community Rating for Heska (HSKA)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  205 (Vote Outperform)
Underperform Votes:  227 (Vote Underperform)
Total Votes:  432
MarketBeat's community ratings are surveys of what our community members think about Heska and other stocks. Vote "Outperform" if you believe HSKA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HSKA will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Heska (NASDAQ:HSKA) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
6 Wall Street analysts have issued ratings and price targets for Heska in the last 12 months. Their average twelve-month price target is $114.90, suggesting that the stock has a possible upside of 12.88%. The high price target for HSKA is $143.00 and the low price target for HSKA is $93.00. There are currently 1 hold rating and 5 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.832.832.832.50
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $114.90$103.10$110.30$105.70
Price Target Upside: 12.88% upside51.66% upside53.69% upside29.28% upside

Heska (NASDAQ:HSKA) Consensus Price Target History

Price Target History for Heska (NASDAQ:HSKA)

Heska (NASDAQ:HSKA) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/21/2018BenchmarkBoost Price TargetBuy$120.00 ➝ $143.00LowView Rating Details
5/18/2018Canaccord GenuityReiterated RatingBuy$100.00 ➝ $115.00LowView Rating Details
5/18/2018B. RileyBoost Price TargetNeutral$77.00 ➝ $93.00LowView Rating Details
2/5/2018SidotiUpgradeNeutral ➝ Buy$94.00LowView Rating Details
12/19/2017AegisReiterated RatingBuyLowView Rating Details
12/4/2017Raymond JamesReiterated RatingBuyHighView Rating Details
1/26/2017CL KingDowngradeBuy ➝ NeutralN/AView Rating Details
8/4/2016GabelliDowngradeBuy ➝ HoldN/AView Rating Details
(Data available from 5/26/2016 forward)


Heska (NASDAQ:HSKA) Earnings History and Estimates Chart

Earnings by Quarter for Heska (NASDAQ:HSKA)

Heska (NASDAQ:HSKA) Earnings Estimates

2018 EPS Consensus Estimate: $2.12
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.37$0.37$0.37
Q2 20181$0.44$0.44$0.44
Q3 20181$0.52$0.52$0.52
Q4 20181$0.79$0.79$0.79

Heska (NASDAQ HSKA) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/4/2018Q1$0.40$0.28$31.65 million$32.77 millionViewN/AView Earnings Details
2/28/2018Q4 2017$0.56$0.63$40.56 million$36.04 millionViewN/AView Earnings Details
11/2/2017Q3 2017$0.37$0.40$36.10 million$31.40 millionViewN/AView Earnings Details
8/3/2017Q2 2017$0.37$0.44$33.35 million$34.30 millionViewN/AView Earnings Details
5/2/2017Q1 2017$0.24$0.61$33.31 million$30.38 millionViewListenView Earnings Details
2/28/2017Q416$0.37$0.46$34.56 million$39.50 millionViewListenView Earnings Details
11/1/2016Q316$0.26$0.45$31.36 million$33.40 millionViewN/AView Earnings Details
8/3/2016Q216$0.18$0.35$28.47 million$30.00 millionViewN/AView Earnings Details
5/3/2016Q116($0.02)$0.17$23.32 million$27.10 millionViewN/AView Earnings Details
3/3/2016Q415$0.17$0.28$28.31 million$29.80 millionViewN/AView Earnings Details
11/11/2015Q315$0.08$0.20$24.31 million$28.00 millionViewListenView Earnings Details
7/29/2015Q215$0.10$0.17$24.11 million$23.90 millionViewListenView Earnings Details
5/7/2015Q115$0.09$0.09$23.97 million$22.90 millionViewN/AView Earnings Details
3/5/2015Q414$0.15$0.12$24.20 million$24.30 millionViewN/AView Earnings Details
10/29/2014Q3 2014($0.01)$0.08$19.39 million$21.81 millionViewN/AView Earnings Details
7/30/2014Q2($0.03)$0.17$19.78 million$22.92 millionViewN/AView Earnings Details
5/8/2014Q1 2014($0.01)$0.03$20.31 million$20.79 millionViewN/AView Earnings Details
3/27/2014$0.04$0.20$18.84 million$23.50 millionViewN/AView Earnings Details
11/6/2013Q3 2013($0.11)$0.04$18.26 million$17.60 millionViewN/AView Earnings Details
8/7/2013Q2 2013($0.01)($0.38)$19.85 million$18.30 millionViewN/AView Earnings Details
5/14/2013Q1 2013$0.12($0.07)$20.94 million$18.98 millionViewN/AView Earnings Details
2/25/2013Q4 2012$0.07$0.07ViewN/AView Earnings Details
11/13/2012Q312$0.08($0.01)$19.70 million$16.90 millionViewN/AView Earnings Details
8/10/2012Q2 2012$0.12$0.05ViewN/AView Earnings Details
5/10/2012Q1 2012$0.01$0.11ViewN/AView Earnings Details
2/17/2012Q4 2011$0.09ViewN/AView Earnings Details
11/14/2011Q3 2011$0.05ViewN/AView Earnings Details
7/27/2011Q2 2011$0.09ViewN/AView Earnings Details
5/5/2011Q1 2011$0.17ViewN/AView Earnings Details
3/9/2011Q4 2010$0.05ViewN/AView Earnings Details
7/20/2010Q2 2010($0.03)ViewN/AView Earnings Details
5/6/2010Q1 2010($0.06)ViewN/AView Earnings Details
2/22/2010Q4 2009$0.09ViewN/AView Earnings Details
10/27/2009Q3 2009$0.14ViewN/AView Earnings Details
8/10/2009Q2 2009$0.11ViewN/AView Earnings Details
4/28/2009Q1 2009($0.04)ViewN/AView Earnings Details
3/16/2009Q4 2008($0.21)ViewN/AView Earnings Details
11/10/2008Q3 2008$0.11ViewN/AView Earnings Details
8/11/2008Q2 2008$0.12ViewN/AView Earnings Details
5/12/2008Q1 2008$0.44ViewN/AView Earnings Details
2/26/2008Q4 2007($0.26)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Heska (NASDAQ:HSKA) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Heska (NASDAQ HSKA) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 14.70%
Institutional Ownership Percentage: 88.16%
Insider Trading History for Heska (NASDAQ:HSKA)
Institutional Ownership by Quarter for Heska (NASDAQ:HSKA)

Heska (NASDAQ HSKA) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/29/2017Michael J McginleyInsiderSell7,826$87.14$681,957.64106,771View SEC Filing  
11/27/2017Michael J McginleyInsiderSell1$88.54$88.54106,771View SEC Filing  
8/31/2017Nancy WisnewskiEVPSell825$102.21$84,323.2538,114View SEC Filing  
8/30/2017John McmahonCFOSell2,608$101.17$263,851.36193View SEC Filing  
6/1/2017Steve AsakowiczEVPSell382$100.08$38,230.5610,382View SEC Filing  
5/31/2017Michael J McginleyInsiderSell11,189$98.53$1,102,452.17111,877View SEC Filing  
5/31/2017Rod LippincottEVPSell11,227$98.00$1,100,246.0011,292View SEC Filing  
5/24/2017Jason A. NapolitanoCOOSell5,000$100.50$502,500.00View SEC Filing  
5/24/2017Nancy WisnewskiEVPSell250$100.17$25,042.5038,901View SEC Filing  
5/23/2017Carol WrennDirectorSell1,630$96.95$158,028.506,174View SEC Filing  
5/23/2017John McmahonCFOSell587$97.00$56,939.00295View SEC Filing  
5/4/2017Sharon J LarsonDirectorBuy1,000$90.00$90,000.003,294View SEC Filing  
4/11/2017Jason A. NapolitanoCOOSell1,100$102.98$113,278.00View SEC Filing  
4/10/2017Jason A. NapolitanoCOOSell3,900$102.94$401,466.00View SEC Filing  
3/9/2017John McmahonCFOSell708$97.42$68,973.36200View SEC Filing  
3/9/2017Rod LippincottEVPSell5,157$97.87$504,715.5910,513View SEC Filing  
3/6/2017Kevin S WilsonCEOSell8,000$90.00$720,000.00110,000View SEC Filing  
1/10/2017Jason A. NapolitanoCOOSell5,000$74.73$373,650.00View SEC Filing  
11/29/2016G Irwin GordonDirectorSell3,000$66.11$198,330.0017,596View SEC Filing  
11/28/2016John McmahonCFOSell1,999$65.64$131,214.36584View SEC Filing  
11/22/2016Rod LippincottEVPSell5,000$64.85$324,250.0010,192View SEC Filing  
9/1/2016Jason A. NapolitanoCFOSell5,000$52.53$262,650.00View SEC Filing  
8/29/2016Kevin S WilsonCEOSell20,000$51.80$1,036,000.00110,000View SEC Filing  
8/24/2016John McmahonVPSell137$51.30$7,028.10View SEC Filing  
8/9/2016Steve AsakowiczEVPSell4,698$52.55$246,879.9012,858View SEC Filing  
8/3/2016Kevin S WilsonCEOSell30,736$47.34$1,455,042.24140,720View SEC Filing  
7/29/2016Kevin S WilsonCEOSell20$43.95$879.00140,736View SEC Filing  
7/20/2016Kevin S WilsonCEOSell3,779$44.02$166,351.58140,756View SEC Filing  
7/18/2016Kevin S WilsonCEOSell5,465$44.31$242,154.15144,535View SEC Filing  
7/8/2016Kevin S WilsonCEOSell10,000$42.37$423,700.00150,000View SEC Filing  
7/7/2016Jason A. NapolitanoCFOSell20,000$41.00$820,000.00View SEC Filing  
7/6/2016Kevin S WilsonCEOSell5,960$40.27$240,009.20160,000View SEC Filing  
7/1/2016Kevin S WilsonCEOSell14,040$38.94$546,717.60165,960View SEC Filing  
6/2/2016Kevin S WilsonCEOSell20,000$36.74$734,800.00190,000View SEC Filing  
5/12/2016Kevin S WilsonCEOSell5,000$38.50$192,500.00200,000View SEC Filing  
5/10/2016Kevin S WilsonCEOSell15,000$36.75$551,250.00210,000View SEC Filing  
5/10/2016Michael J McginleyInsiderSell5,998$36.50$218,927.0030,801View SEC Filing  
5/10/2016Sharon L RileyDirectorSell5,000$36.87$184,350.009,500View SEC Filing  
5/9/2016Kevin S WilsonCEOSell11,000$35.61$391,710.00228,718View SEC Filing  
5/5/2016Sharon L RileyDirectorSell15,000$35.66$534,900.009,500View SEC Filing  
5/3/2016Jason A NapolitanoCFOSell5,000$35.75$178,750.0063,544View SEC Filing  
3/8/2016Sharon L RileyDirectorBuy1,000$32.49$32,490.005,500View SEC Filing  
1/27/2016Jason A NapolitanoCFOSell15,000$37.00$555,000.0051,900View SEC Filing  
12/29/2015Jason A. NapolitanoCFOSell3,700$40.03$148,111.0066,900View SEC Filing  
12/3/2015Kevin S WilsonCEOSell6,000$35.50$213,000.00230,000View SEC Filing  
11/25/2015Michael J. McginleyinsiderSell958$33.62$32,207.9615,928View SEC Filing  
11/24/2015Michael J. McginleyinsiderSell1,427$33.33$47,561.9115,928View SEC Filing  
9/11/2015Jason A NapolitanoCFOSell1,699$33.51$56,933.4958,100View SEC Filing  
8/31/2015Jason A. NapolitanoCFOSell4,998$33.59$167,882.8259,799View SEC Filing  
8/31/2015Robert B. GrieveinsiderSell11,098$33.77$374,779.46101,690View SEC Filing  
8/27/2015Robert B. GrieveinsiderSell3,604$33.79$121,779.16101,690View SEC Filing  
8/17/2015Kevin S WilsonCEOSell2,498$34.90$87,180.20View SEC Filing  
8/17/2015Robert B GrieveInsiderSell8,033$34.91$280,432.03View SEC Filing  
8/14/2015Kevin S WilsonCEOSell2,101$34.90$73,324.90View SEC Filing  
8/14/2015Rod LippincottEVPSell3,898$34.19$133,272.62View SEC Filing  
7/13/2015Robert B GrieveInsiderSell1,000$29.99$29,990.00View SEC Filing  
6/8/2015Kevin S WilsonCEOSell11,810$30.08$355,244.80View SEC Filing  
6/3/2015Robert B GrieveInsiderSell17,000$31.36$533,120.00View SEC Filing  
6/1/2015Jason A NapolitanoCFOSell7,536$32.26$243,111.36View SEC Filing  
5/22/2015Steven M EylEVPSell5,981$30.19$180,566.39View SEC Filing  
4/24/2015Robert B GrieveInsiderSell6,000$29.67$178,020.00View SEC Filing  
4/13/2015Robert B GrieveInsiderSell4,000$26.54$106,160.00View SEC Filing  
3/9/2015Jason A NapolitanoCFOSell5,765$26.02$150,005.30View SEC Filing  
3/9/2015Kevin S WilsonCEOSell10,000$25.38$253,800.00View SEC Filing  
3/9/2015Robert B GrieveInsiderSell2,000$25.26$50,520.00View SEC Filing  
11/30/2014David E SveenDirectorBuy21,428$14.00$299,992.00View SEC Filing  
11/30/2014Kevin S WilsonCEOSell28,928$14.00$404,992.00View SEC Filing  
11/21/2014Robert B GrieveInsiderSell6,500$15.25$99,125.00View SEC Filing  
11/3/2014William A AylesworthDirectorSell5,000$13.67$68,350.00View SEC Filing  
8/4/2014Robert B GrieveDirectorSell12,000$13.57$162,840.00View SEC Filing  
5/14/2014William AylesworthDirectorSell4,200$10.89$45,738.0029,797View SEC Filing  
3/31/2014Carol WrennDirectorBuy1,000$10.50$10,500.004,000View SEC Filing  
3/31/2014Robert GrieveCEOSell7,000$10.50$73,500.00143View SEC Filing  
3/1/2013William A AylesworthDirectorBuy2,000$8.34$16,680.00View SEC Filing  
10/3/2012Master Fund L.P. CmcMajor ShareholderSell11,002$9.54$104,959.08View SEC Filing  
8/28/2012William A AylesworthDirectorBuy2,000$7.95$15,900.00View SEC Filing  
(Data available from 1/1/2013 forward)


Heska (NASDAQ HSKA) News Headlines

Heska Co. (HSKA) Receives Average Rating of "Buy" from AnalystsHeska Co. (HSKA) Receives Average Rating of "Buy" from Analysts - May 25 at 1:40 PM
Recent Analysis Shows Alexanders, American National Insurance, VAREX IMAGING, Banner, Instructure,Recent Analysis Shows Alexander's, American National Insurance, VAREX IMAGING, Banner, Instructure, - May 24 at 8:33 AM
 Analysts Anticipate Heska Co. (HSKA) Will Announce Quarterly Sales of $30.19 Million Analysts Anticipate Heska Co. (HSKA) Will Announce Quarterly Sales of $30.19 Million - May 24 at 2:14 AM
Zacks: Analysts Anticipate Heska Co. (HSKA) to Announce $0.17 EPSZacks: Analysts Anticipate Heska Co. (HSKA) to Announce $0.17 EPS - May 22 at 7:18 PM
Benchmark Raises Heska (HSKA) Price Target to $143.00Benchmark Raises Heska (HSKA) Price Target to $143.00 - May 21 at 11:25 AM
Heska Co. to Post Q4 2018 Earnings of $0.79 Per Share, B. Riley Forecasts (HSKA)Heska Co. to Post Q4 2018 Earnings of $0.79 Per Share, B. Riley Forecasts (HSKA) - May 21 at 1:26 AM
Heska: Pets Are People TooHeska: Pets Are People Too - May 18 at 5:39 PM
Canaccord Genuity Reaffirms Buy Rating for Heska (HSKA)Canaccord Genuity Reaffirms Buy Rating for Heska (HSKA) - May 18 at 5:13 PM
Heska (HSKA) Price Target Raised to $93.00Heska (HSKA) Price Target Raised to $93.00 - May 18 at 4:13 PM
Wired News – Heska Collaborates with MBio Diagnostics for Developing New Products for the Veterinary MarketWired News – Heska Collaborates with MBio Diagnostics for Developing New Products for the Veterinary Market - May 17 at 8:39 AM
Heska: Margin Expansion OpportunityHeska: Margin Expansion Opportunity - May 9 at 5:19 PM
B. Riley Comments on Heska Co.s Q2 2018 Earnings (HSKA)B. Riley Comments on Heska Co.'s Q2 2018 Earnings (HSKA) - May 9 at 8:45 AM
Heska (HSKA) Upgraded to Strong-Buy at BidaskClubHeska (HSKA) Upgraded to Strong-Buy at BidaskClub - May 8 at 10:22 AM
B. Riley Comments on Heska Co.s Q3 2018 Earnings (HSKA)B. Riley Comments on Heska Co.'s Q3 2018 Earnings (HSKA) - May 8 at 7:12 AM
Heska (HSKA) Receives Buy Rating from Canaccord GenuityHeska (HSKA) Receives Buy Rating from Canaccord Genuity - May 7 at 2:57 PM
Heska (HSKA) Price Target Raised to $100.00 at BenchmarkHeska (HSKA) Price Target Raised to $100.00 at Benchmark - May 7 at 2:56 PM
$33.75 Million in Sales Expected for Heska Co. (HSKA) This Quarter$33.75 Million in Sales Expected for Heska Co. (HSKA) This Quarter - May 7 at 4:23 AM
Heskas (HSKA) CEO Kevin Wilson on Q1 2018 Results - Earnings Call TranscriptHeska's (HSKA) CEO Kevin Wilson on Q1 2018 Results - Earnings Call Transcript - May 6 at 7:23 PM
Heska (HSKA) Upgraded by ValuEngine to "Hold"Heska (HSKA) Upgraded by ValuEngine to "Hold" - May 5 at 2:27 PM
Heska Co. (HSKA) Expected to Post Earnings of $0.50 Per ShareHeska Co. (HSKA) Expected to Post Earnings of $0.50 Per Share - May 5 at 11:37 AM
Heska (HSKA) Misses Q1 EPS by 7cHeska (HSKA) Misses Q1 EPS by 7c - May 5 at 8:43 AM
Edited Transcript of HSKA earnings conference call or presentation 4-May-18 3:00pm GMTEdited Transcript of HSKA earnings conference call or presentation 4-May-18 3:00pm GMT - May 5 at 8:43 AM
Heska (HSKA) Issues  Earnings ResultsHeska (HSKA) Issues Earnings Results - May 4 at 8:33 PM
BRIEF-Heska Reports Q1 Earnings Per Share Of $0.28BRIEF-Heska Reports Q1 Earnings Per Share Of $0.28 - May 4 at 5:15 PM
Heska misses by $0.07, beats on revenueHeska misses by $0.07, beats on revenue - May 4 at 8:32 AM
Heska Reports First Quarter ResultsHeska Reports First Quarter Results - May 4 at 8:32 AM
Heska: 1Q Earnings SnapshotHeska: 1Q Earnings Snapshot - May 4 at 8:32 AM
Heska (HSKA) Raised to Hold at Zacks Investment ResearchHeska (HSKA) Raised to Hold at Zacks Investment Research - May 3 at 11:51 PM
Why Heska (HSKA) Might Surprise This Earnings SeasonWhy Heska (HSKA) Might Surprise This Earnings Season - May 3 at 5:11 PM
Heska to Present at Upcoming Conferences in May & June 2018Heska to Present at Upcoming Conferences in May & June 2018 - May 3 at 8:30 AM
Heska Corporation Announces Board ActionHeska Corporation Announces Board Action - May 2 at 5:23 PM
Heska to Host Analyst and Investor Day on May 15Heska to Host Analyst and Investor Day on May 15 - May 2 at 8:36 AM
Heska Co. (HSKA) Given Consensus Recommendation of "Hold" by BrokeragesHeska Co. (HSKA) Given Consensus Recommendation of "Hold" by Brokerages - April 30 at 1:36 PM
Heska Names EVP, International Diagnostics, to Accelerate International ExpansionHeska Names EVP, International Diagnostics, to Accelerate International Expansion - April 30 at 8:38 AM
Heska (HSKA) to Release Quarterly Earnings on FridayHeska (HSKA) to Release Quarterly Earnings on Friday - April 27 at 1:16 AM
Head to Head Contrast: Heska (HSKA) and Its CompetitorsHead to Head Contrast: Heska (HSKA) and Its Competitors - April 25 at 5:16 PM
Heska Confirms Details for Annual Meeting of Stockholders on May 3, 2018Heska Confirms Details for Annual Meeting of Stockholders on May 3, 2018 - April 25 at 8:33 AM
Head-To-Head Review: Heska (HSKA) vs. Solid Biosciences (SLDB)Head-To-Head Review: Heska (HSKA) vs. Solid Biosciences (SLDB) - April 25 at 3:06 AM
Heska (HSKA) Upgraded to Buy by BidaskClubHeska (HSKA) Upgraded to Buy by BidaskClub - April 21 at 7:06 AM
$31.65 Million in Sales Expected for Heska Co. (HSKA) This Quarter$31.65 Million in Sales Expected for Heska Co. (HSKA) This Quarter - April 20 at 4:02 AM
Heska Co. (HSKA) Expected to Announce Earnings of $0.40 Per ShareHeska Co. (HSKA) Expected to Announce Earnings of $0.40 Per Share - April 18 at 9:22 AM
Comparing Heska (HSKA) and The CompetitionComparing Heska (HSKA) and The Competition - April 16 at 11:10 PM
Heska (HSKA) Earns Neutral Rating from B. RileyHeska (HSKA) Earns Neutral Rating from B. Riley - April 13 at 9:58 PM
Heska (HSKA) PT Raised to $120.00Heska (HSKA) PT Raised to $120.00 - April 13 at 5:29 PM
Heska (HSKA) Upgraded at BidaskClubHeska (HSKA) Upgraded at BidaskClub - April 13 at 4:23 PM
Heska: Attractive OpportunityHeska: Attractive Opportunity - April 12 at 5:21 PM
Heska (HSKA) Receives "Buy" Rating from BenchmarkHeska (HSKA) Receives "Buy" Rating from Benchmark - April 12 at 3:58 PM
Heska (HSKA) Stock Rating Lowered by BidaskClubHeska (HSKA) Stock Rating Lowered by BidaskClub - April 10 at 3:54 PM
Heska Schedules First Quarter 2018 Financial Results Conference Call for May 4, 2018Heska Schedules First Quarter 2018 Financial Results Conference Call for May 4, 2018 - April 10 at 8:48 AM
Analyzing Heska (HSKA) and Its CompetitorsAnalyzing Heska (HSKA) and Its Competitors - April 8 at 3:08 AM

SEC Filings

Heska (NASDAQ:HSKA) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Heska (NASDAQ:HSKA) Income Statement, Balance Sheet and Cash Flow Statement


Heska (NASDAQ HSKA) Stock Chart for Saturday, May, 26, 2018

Loading chart…

This page was last updated on 5/26/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.